...
首页> 外文期刊>Investigative ophthalmology & visual science >BH4-Mediated Enhancement of Endothelial Nitric Oxide Synthase Activity Reduces Hyperoxia-Induced Endothelial Damage and Preserves Vascular Integrity in the Neonate
【24h】

BH4-Mediated Enhancement of Endothelial Nitric Oxide Synthase Activity Reduces Hyperoxia-Induced Endothelial Damage and Preserves Vascular Integrity in the Neonate

机译:BH4介导的内皮一氧化氮合酶活性的增强减少了高氧血症引起的内皮损伤,并保留了新生儿的血管完整性。

获取原文

摘要

Purpose: Endothelial nitric oxide synthase (eNOS)-derived nitric oxide (NO) has important vasoprotective functions that are compromised in the vasodegenerative phase of retinopathy of prematurity, owing to hyperoxia-induced depletion of the essential NOS cofactor BH4. Because modulating eNOS function can be beneficial or detrimental, our aim was to investigate the effect of BH4 supplementation on eNOS function and vascular regression in hyperoxia. Methods: Endothelial-specific eNOS-green fluorescent protein (GFP) overexpressing mice at postnatal day 7 (P7) were exposed to hyperoxia for 48 hours in the presence or absence of supplemental BH4, achieved by administration of sepiapterin, a stable BH4 precursor. Tissue was collected either for retinal flat mounts that were stained with lectin to determine the extent of vessel coverage or for analysis of BH4 by high-performance liquid chromatography, nitrotyrosine (NT) marker by Western blotting, VEGF expression by ELISA, and NOS activity by arginine-to-citrulline conversion. Primary retinal microvascular endothelial cells (RMEC) were similarly treated, and hyperoxia-induced damage was determined. Results: Sepiapterin effectively enhanced BH4 levels in hyperoxia-exposed retinas and brains, elevated NOS activity, and reduced NT-modified protein, leading to reversal of the exacerbated vasoregression observed in the presence of eNOS overexpression. In RMECs, hyperoxia-mediated depletion of BH4 dysregulated the redox balance by reducing nitrite and elevating superoxide and impaired proliferative ability. BH4 supplementation restored normal RMEC proliferation in vitro and also in vivo, providing a mechanistic link with the enhanced vascular coverage in eNOS-GFP retinas. Conclusions: These results demonstrate that BH4 supplementation corrects hyperoxia-induced RMEC dysfunction and preserves vascular integrity by enhancing eNOS function.
机译:目的:内皮一氧化氮合酶(eNOS)衍生的一氧化氮(NO)具有重要的血管保护功能,由于高氧诱导的必需NOS辅因子BH4耗竭,因此在早熟视网膜病变的血管生成阶段受到损害。由于调节eNOS功能可能有益或有害,因此我们的目的是研究补充BH4对高氧血症中eNOS功能和血管退化的影响。方法:在存在或不存在补充BH4的情况下,在出生后第7天(P7)过表达内皮特异性eNOS-绿色荧光蛋白(GFP)的小鼠高氧48小时,这是通过施用稳定的BH4前体Sepiapterin实现的。收集组织以进行凝集素染色以测定血管覆盖程度的视网膜平坦固定物,或通过高效液相色谱法分析BH4,通过Western印迹法检测硝基酪氨酸(NT)标记,通过ELISA法检测VEGF的表达以及通过检测NOS活性的方法精氨酸到瓜氨酸的转化。对视网膜原代微血管内皮细胞(RMEC)进行类似处理,并确定高氧诱导的损伤。结果:Sepaapterin有效地提高了高氧暴露的视网膜和大脑中的BH4水平,提高了NOS活性,并减少了NT修饰的蛋白,导致存在eNOS过表达时观察到的血管舒张加剧。在RMEC中,高氧介导的BH4耗竭通过减少亚硝酸盐,升高超氧化物和损害增殖能力来失调氧化还原平衡。 BH4补充剂在体外和体内恢复了正常的RMEC增殖,与eNOS-GFP视网膜中血管覆盖的增强提供了机械联系。结论:这些结果表明,补充BH4可通过增强eNOS功能来纠正高氧诱导的RMEC功能障碍并保留血管完整性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号